# Morphosis Capital

Morphosis Capital is a Private Equity based in Bucharest, Romania.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bucharest, Romania
- **Region:** Europe
- **Address:** Bucharest, Romania
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** morphosiscapital.com
- **LinkedIn:** https://www.linkedin.com/company/morphosis-capital

## Regulatory record

- **Reports private funds:** No

## About

Morphosis Capital is a private equity firm founded in 2018 in Bucharest, Romania. It focuses on supporting high-growth companies through capital and strategic support. The firm invests in established companies with growth potential, primarily in sectors offering competitive products or services.

## Sectors

- Healthcare Services
- Education
- SpaceTech
- Industrial Tech
- Retail
- Wellness
- Enterprise Software

## Offices

- The Hague, Netherlands
- Amsterdam, Netherlands

## People

- Andrei Gemeneanu — Managing Partner
- Simona Gemeneanu — Partner
- Dragos Petre — Partner & CFO
- Gabriela Dumitru — Partner
- Adrian Netea — Investment Director
- David Masculic, CFA — Investment Director

## Questions

### Who runs investment decisions at Morphosis Capital?

The firm is led by four partners: Managing Partner Andrei Gemeneanu, Partners Simona Gemeneanu and Gabriela Dumitru, and Partner & CFO Dragos Petre. They describe themselves as former entrepreneurs who now make investment decisions by committee, applying an operator's lens to every deal. The investment team also includes two investment directors and three associates and analysts.

### How does Morphosis Capital source proprietary deal flow?

Morphosis relies on a founder-centric sourcing model. The partners position themselves as entrepreneurs who understand operating challenges, which they argue draws founder referrals in a CEE market where owner-operators often distrust financial buyers. The firm targets fragmented, growing industries in Romania and neighboring CEE countries, seeking businesses that haven't been approached by institutional capital.

### Does Morphosis Capital participate in fund commitments or only direct deals?

Morphosis makes only direct investments into operating companies. It targets equity tickets of €10–15 million, with the flexibility to take minority or majority positions. The firm does not market a fund-of-funds program or invest in third-party GPs. It also executes bolt-on acquisitions for portfolio companies, having completed bolt-ons between 2021 and 2023.

### What investment stages does Morphosis Capital target?

The firm targets growth equity and expansion-stage companies with EBITDA of €1–5 million at entry. It avoids early-stage venture and startups without proven unit economics. Fund I required minimum EBITDA of €500,000, but Fund II raised the floor to €1 million, tightening the focus on later-stage, profitable SMEs.

### Which sectors does Morphosis Capital explicitly avoid?

Morphosis publicly lists four targets — healthcare, consumer products and services, niche manufacturing, and B2B services — but does not list explicit sector exclusions. The website and portfolio show no exposure to financial services, software infrastructure, or energy transition. Its investments cluster in brick-and-mortar healthcare, industrials, and consumer-facing businesses.

## Related profiles

- [Morpho Capital Partners](https://altss.com/profile/morpho-capital-partners)
- [Morphosis Venture Capital](https://altss.com/profile/morphosis-venture-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/morphosis-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology